口腔科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 口腔科威廉亚洲博彩公司

乳牙牙髓病诊疗威廉亚洲博彩公司

2021-09-09 中华口腔医学会 中华口腔医学杂志. 2021,56(09)

乳牙

乳牙牙髓病是危害我国儿童口腔健康的常见疾病之一。针对我国乳牙牙髓病及根尖周病的诊断及治疗水平参差不齐,治疗术式选择不一的问题,中华口腔医学会儿童口腔医学专业委员会召集专家进行专题讨论,同时借鉴和参考国

中文标题：

乳牙牙髓病诊疗威廉亚洲博彩公司

发布机构：

中华口腔医学会

发布日期：

2021-09-09

简要介绍：

乳牙牙髓病是危害我国儿童口腔健康的常见疾病之一。针对我国乳牙牙髓病及根尖周病的诊断及治疗水平参差不齐,治疗术式选择不一的问题,中华口腔医学会儿童口腔医学专业委员会召集专家进行专题讨论,同时借鉴和参考国内外乳牙牙髓及根尖周病的研究成果与诊治经验,制订此标准。本威廉亚洲博彩公司 中乳牙牙髓治疗包括间接牙髓治疗术、牙髓切断术和根管治疗术(牙髓摘除术)。由于对乳牙直接盖髓术的适应证选择尚未达成共识,故此项内容未纳入本威廉亚洲博彩公司 。
 

相关资料下载：
[AttachmentFileName(sort=1, fileName=乳牙牙髓病诊疗威廉亚洲博彩公司 .pdf)] GetToolGuiderByIdResponse(projectId=1, id=11c091c002192a26, title=乳牙牙髓病诊疗威廉亚洲博彩公司 , enTitle=, guiderFrom=中华口腔医学杂志. 2021,56(09), authorId=0, author=, summary=乳牙牙髓病是危害我国儿童口腔健康的常见疾病之一。针对我国乳牙牙髓病及根尖周病的诊断及治疗水平参差不齐,治疗术式选择不一的问题,中华口腔医学会儿童口腔医学专业委员会召集专家进行专题讨论,同时借鉴和参考国, cover=https://img.medsci.cn/2021923/1632411486802_2020535.jpg, journalId=0, articlesId=null, associationId=232, associationName=中华口腔医学会, associationIntro=中华口腔医学会是口腔医学科学技术工作者自愿结成的全国性学术性群众团体，为非营利性社会组织，是依法成立的社团法人，是政府联系口腔医学科学技术工作者的纽带和桥梁，是发展我国口腔医学科学的社会力量。学会成立于1996年11月7日，她的前身是1951年成立的中华医学会口腔科学会。 学会成立以来，全国各省市的口腔分会亦争取从省、直辖市医学会中独立出来，成立省、直辖市口腔医学会。省市口腔医学会一成立即成为中华口腔医学会的团体会员，除对学会有业务指导关系外，尚的对团体会员的领导作用。, copyright=0, guiderPublishedTime=Thu Sep 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">乳牙牙髓病是危害我国儿童口腔健康的常见疾病之一。针对我国乳牙牙髓病及根尖周病的诊断及治疗水平参差不齐,治疗术式选择不一的问题,中华口腔医学会儿童口腔医学专业委员会召集专家进行专题讨论,同时借鉴和参考国内外乳牙牙髓及根尖周病的研究成果与诊治经验,制订此标准。本威廉亚洲博彩公司 中乳牙牙髓治疗包括间接牙髓治疗术、牙髓切断术和根管治疗术(牙髓摘除术)。由于对乳牙直接盖髓术的适应证选择尚未达成共识,故此项内容未纳入本威廉亚洲博彩公司 。</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=27112, tagName=乳牙)], categoryList=[CategoryDto(categoryId=31, categoryName=口腔科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=25498, guiderKeyword=牙髓病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7132, appHits=141, showAppHits=0, pcHits=941, showPcHits=6989, likes=1, shares=19, comments=12, approvalStatus=1, publishedTime=Thu Sep 23 23:40:40 CST 2021, publishedTimeString=2021-09-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 23 23:38:22 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 12:41:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=乳牙牙髓病诊疗威廉亚洲博彩公司 .pdf)])
乳牙牙髓病诊疗威廉亚洲博彩公司 .pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1248298, encodeId=292112482980b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9e58318930, createdName=ms2000001284969307, createdTime=Sat Sep 10 18:44:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214535, encodeId=e10812145358c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c522428072, createdName=123adf11m26暂无昵称, createdTime=Tue Apr 26 14:09:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200601, encodeId=30ab1200601af, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:12:37 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080802, encodeId=dcd8108080280, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211216/3527b5098e57463ea9b8c67cb59bd287/dc48dff575294b8584cfd46818b5761f.jpg, createdBy=12ff6407182, createdName=小吸, createdTime=Thu Dec 16 17:14:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077875, encodeId=d37810e787592, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/0ecb94134b5d44809bff0b2827d118fc/dd31500bd91643d288a81bf8c1ea9b60.jpg, createdBy=26465422468, createdName=ms2000001977989574, createdTime=Tue Dec 07 21:51:00 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-09-10 ms2000001284969307

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1248298, encodeId=292112482980b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9e58318930, createdName=ms2000001284969307, createdTime=Sat Sep 10 18:44:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214535, encodeId=e10812145358c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c522428072, createdName=123adf11m26暂无昵称, createdTime=Tue Apr 26 14:09:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200601, encodeId=30ab1200601af, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:12:37 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080802, encodeId=dcd8108080280, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211216/3527b5098e57463ea9b8c67cb59bd287/dc48dff575294b8584cfd46818b5761f.jpg, createdBy=12ff6407182, createdName=小吸, createdTime=Thu Dec 16 17:14:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077875, encodeId=d37810e787592, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/0ecb94134b5d44809bff0b2827d118fc/dd31500bd91643d288a81bf8c1ea9b60.jpg, createdBy=26465422468, createdName=ms2000001977989574, createdTime=Tue Dec 07 21:51:00 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-04-26 123adf11m26暂无昵称

    值得学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1248298, encodeId=292112482980b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9e58318930, createdName=ms2000001284969307, createdTime=Sat Sep 10 18:44:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214535, encodeId=e10812145358c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c522428072, createdName=123adf11m26暂无昵称, createdTime=Tue Apr 26 14:09:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200601, encodeId=30ab1200601af, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:12:37 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080802, encodeId=dcd8108080280, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211216/3527b5098e57463ea9b8c67cb59bd287/dc48dff575294b8584cfd46818b5761f.jpg, createdBy=12ff6407182, createdName=小吸, createdTime=Thu Dec 16 17:14:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077875, encodeId=d37810e787592, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/0ecb94134b5d44809bff0b2827d118fc/dd31500bd91643d288a81bf8c1ea9b60.jpg, createdBy=26465422468, createdName=ms2000001977989574, createdTime=Tue Dec 07 21:51:00 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-03-08 gghhzb

    值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1248298, encodeId=292112482980b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9e58318930, createdName=ms2000001284969307, createdTime=Sat Sep 10 18:44:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214535, encodeId=e10812145358c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c522428072, createdName=123adf11m26暂无昵称, createdTime=Tue Apr 26 14:09:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200601, encodeId=30ab1200601af, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:12:37 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080802, encodeId=dcd8108080280, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211216/3527b5098e57463ea9b8c67cb59bd287/dc48dff575294b8584cfd46818b5761f.jpg, createdBy=12ff6407182, createdName=小吸, createdTime=Thu Dec 16 17:14:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077875, encodeId=d37810e787592, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/0ecb94134b5d44809bff0b2827d118fc/dd31500bd91643d288a81bf8c1ea9b60.jpg, createdBy=26465422468, createdName=ms2000001977989574, createdTime=Tue Dec 07 21:51:00 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-16 小吸

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1248298, encodeId=292112482980b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9e58318930, createdName=ms2000001284969307, createdTime=Sat Sep 10 18:44:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214535, encodeId=e10812145358c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c522428072, createdName=123adf11m26暂无昵称, createdTime=Tue Apr 26 14:09:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200601, encodeId=30ab1200601af, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:12:37 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080802, encodeId=dcd8108080280, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211216/3527b5098e57463ea9b8c67cb59bd287/dc48dff575294b8584cfd46818b5761f.jpg, createdBy=12ff6407182, createdName=小吸, createdTime=Thu Dec 16 17:14:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077875, encodeId=d37810e787592, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/0ecb94134b5d44809bff0b2827d118fc/dd31500bd91643d288a81bf8c1ea9b60.jpg, createdBy=26465422468, createdName=ms2000001977989574, createdTime=Tue Dec 07 21:51:00 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-07 ms2000001977989574

    学习了

    0

拓展阅读

2017 ESE立场声明：牙髓病学中抗生素的应用

欧洲牙髓病学学会(ESE,European Society of Endodontology) · 2017-04-24

欧洲牙髓病学会（ESE）关于“牙髓病治疗中抗生素使用”的立场声明

暂未更新 · 2017-05-09

2023 欧洲牙髓学学会(ESE)S3级临床实践威廉亚洲博彩公司 ：治疗牙髓和牙尖疾病

暂未更新 · 2023-09-29

牙髓治疗难度评估专家共识

暂未更新 · 2024-03-01

牙髓病S3级临床实践威廉亚洲博彩公司 ：欧洲牙髓病学会的制订流程与建议

欧洲牙髓病学学会(ESE,European Society of Endodontology) · 2025-04-11